CN Patent

CN106389381A — 金刚烷胺组合物及其使用方法

Assigned to Adamas Pharmaceuticals Inc · Expires 2017-02-15 · 9y expired

What this patent protects

本申请描述了在夜间施用金刚烷胺以减轻正在接受金刚烷胺治疗的患者的睡眠障碍的方法，以及适合在夜间施用的缓释金刚烷胺组合物。

USPTO Abstract

本申请描述了在夜间施用金刚烷胺以减轻正在接受金刚烷胺治疗的患者的睡眠障碍的方法，以及适合在夜间施用的缓释金刚烷胺组合物。

Drugs covered by this patent

amantadine-hydrochloride (AMANTADINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN106389381A
Jurisdiction: CN
Classification: —
Expires: 2017-02-15
Drug substance claim: No
Drug product claim: No
Assignee: Adamas Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.